Barclays
ABVC icon

Barclays’s ABVC BioPharma ABVC Stock Holding History

Barclays’s Portfolio ABVC Stock Details ABVC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2 Buy
+2
New +$2 ﹤0.01% 5298

Other funds holding ABVC

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Caitong International Asset Management
Caitong International Asset Management Hong Kong $1.04B AUM 150.25% 1-Year Est. Return
SBI Securities
SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

Barclays's ABVC Position: Q3 2026 in Review

Barclays opened a new position in ABVC BioPharma (ABVC) in Q3 2026: 2 shares worth $2. The stake represents ﹤0.01% of the portfolio and ranks #5298 among its holdings.

4 funds tracked by Wall St. Rank hold ABVC as of Q3 2026.

  • Barclays held 2 shares of ABVC BioPharma worth $2 as of Q3 2026.
  • ABVC BioPharma was a new Barclays position in Q3 2026.
  • ABVC BioPharma made up ﹤0.01% of Barclays's portfolio in Q3 2026, its #5298 holding.
  • 4 funds tracked by Wall St. Rank held ABVC BioPharma as of Q3 2026.

Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.